CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 220 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 4.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $2,000 | -75.0% | 187 | -70.4% | 0.00% | – |
Q3 2019 | $8,000 | +33.3% | 632 | +6.8% | 0.00% | – |
Q2 2019 | $6,000 | -85.4% | 592 | -82.9% | 0.00% | – |
Q1 2019 | $41,000 | -67.2% | 3,456 | -63.3% | 0.00% | -100.0% |
Q4 2018 | $125,000 | -20.9% | 9,415 | -16.9% | 0.00% | -50.0% |
Q3 2018 | $158,000 | -12.2% | 11,325 | -1.2% | 0.00% | 0.0% |
Q2 2018 | $180,000 | +39.5% | 11,468 | +46.6% | 0.00% | 0.0% |
Q1 2018 | $129,000 | -46.0% | 7,823 | -40.6% | 0.00% | -33.3% |
Q4 2017 | $239,000 | +334.5% | 13,173 | +355.0% | 0.00% | +200.0% |
Q3 2017 | $55,000 | -5.2% | 2,895 | -41.4% | 0.00% | 0.0% |
Q2 2017 | $58,000 | +383.3% | 4,938 | +337.8% | 0.00% | – |
Q1 2017 | $12,000 | – | 1,128 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |